Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation

Journal of Clinical Oncology

Volumn 20, Issue 19, 2002, Pages 4015-4021

  Freedman, Gary M ^a   Hanlon, A L ^a   Fowble, B L ^a   Anderson, P R ^a   Nicoloau, N ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 0036787582     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.03.155     Document Type: Article

References (57)

1. van Dongen J, Voogd AC, Fentiman IS, et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143-1150, 2000
2. Fisher B, Anderson S, Redmond CK, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995
3. Arriagada R, Lê MG, Rochard F, et al: Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data. J Clin Oncol 14:1558-1564, 1996
4. Touboul E, Buffat L, Belkacémi Y, et al: Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43:25-38, 1999
5. Fortin A, Larochelle M, Laverdière J, et al: Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17:101-109, 1999
6. Kini VR, Vicini FA, Frazier R, et al: Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 43:341-346, 1999
7. Jacobson JA, Danforth DN, Cowan KH, et al: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332:907-911, 1995
8. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57, 1996
9. Stotter AT, McNeese MD, Ames FC, et al: Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64:2217-2225, 1989
10. Kurtz JM, Spitalier J-M, Amalric R, et al: The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 18:87-93, 1990
11. Kim SH, Simkovich-Heerdt A, Tran KN, et al: Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg 187:1-8, 1998
12. Cowen D, Jacquemier J, Houvenaeghel G, et al: Local and distant recurrence after conservative mamangement of "very low-risk" breast cancer are dependent events: A 10-year follow-up. Int J Radiat Oncol Biol Phys 41:801-807, 1998
13. Fourquet A, Campana F, Zafrani B, et al: Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 17:719-725, 1989
14. Albain KS, Green S, LeBlanc M, et al: Proportional hazards and recursive partitioning and amalgamation analysis of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: A pilot study. Breast Cancer Res Treat 22:273-284, 1992
15. American Joint Committee on Cancer: AJCC Cancer Staging Manual. Philadelphia, PA, Lippincott-Raven, 1997
16. Schnitt SJ, Connolly JL, Harris, JR, et al: Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 53:1049-1057, 1984
17. Fowble B: Conservative surgery and radiation for early breast cancer, in Fowble B, Goodman R, Glick J, et al (eds): Breast Cancer Treatment: A Comprehensive Guide to Management. St Louis, MO, Mosby Yearbook, 1991, pp 105-149
18. Segal M: Regression trees for censored data. Biometrics 44:35-48, 1988
19. Zhang HP, Singer B: Recursive Partitioning in the Health Sciences. New York, NY, Springer, 1999
20. Ciampi A, Hogg A, McKinney S, et al: A computer program for recursive partitioning and amalgamation for censored survival data. Comput Methods Programs Biomed 26:239-256, 1988
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Veronesi U, Salvadori B, Luini A, et al: Breast conservation is a safe method in patients with small cancer of the breast: Long-term results of three randomized trials on 1,973 patients. Eur J Cancer 31A:1574-1579, 1995
23. Bouvet M, Babiera GV, Tucker SL, et al: Does breast conservation therapy in young women with breast cancer adversely affect local disease control and survival rate? The M.D. Anderson Cancer Center experience. Breast J 3:169-175, 1997
24. Fowble BL, Schultz DJ, Overmoyer B, et al: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30:23-33, 1994
25. Kurtz JM, Jacquemier J, Amalric R, et al: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8:591-598, 1990
26. Veronesi U, Marubini E, Del Vecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
27. Fisher ER, Anderson S, Redmond C, et al: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathologic findings from NSABP protocol B-06. Semin Surg Oncol 8:161-166, 1992
28. Elkhuizen PHM, van de Vijver MJ, Hermans J, et al: Local recurrence after breast-conserving therapy for invasive breast cancer: High incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40:859-867, 1998
29. Borger J, Kemperman H, Hart A, et al: Risk factors in breast-conservation therapy. J Clin Oncol 12:653-660, 1994
30. Voogd AC, Peterse JL, Crommelin MA, et al: Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Eur J Cancer 35:1828-1837, 1999
31. Dewar JA, Arriagada R, Benhamou S, et al: Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). Cancer 76:2260-2265, 1995
32. Leborgne F, Leborgne JH, Ortega B, et al: Breast conservation treatment of early stage breast cancer: Patterns of failure. Iht J Radiat Oncol Biol Phys 31:765-775, 1995
33. Cowen D, Houvenaeghel G, Bardou V-J, et al: Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 47:305-312, 2000
34. Burke M-F, Allison R, Tripcony L: Conservative therapy of breast cancer in Queensland. Int J Radiat Oncol Biol Phys 31:295-303, 1995
35. Gage I, Schnitt SJ, Nixon AJ, et al: Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78:1921-1928, 1996
36. Solin LJ, Fowble BL, Yeh I, et al: Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23:961-968, 1992
37. Smitt MC, Nowels KW, Zdeblick MJ, et al: The importance of lumpectomy surgical margin status in long term results of breast conservation. Cancer 76:259-267, 1995
38. Park CC, Mitsumori MM, Nixon A, et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668-1675, 2000
39. Freedman G, Fowble B, Hanlon A, et al: Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44:1005-1015, 1999
40. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al: Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 40:851-858, 1998
41. Obedian E, Haffty BG: Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 6:28-33, 1999
42. Peterson ME, Schultz DJ, Reynolds C, et al: Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 43:1029-1035, 1999
43. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al: The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 45:885-891, 1999
44. Wazer DE, Morr J, Erban JK, et al: The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer 80:732-740, 1997
45. Fowble B, Fein DA, Hanlon AL, et al: The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 35:669-677, 1996
46. Dalberg K, Johansson H, Johansson U, et al: A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Cancer 82:2204-2211, 1998
47. Fisher B, Dignam J, Bryant J, et al: Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 88:1529-1542, 1996
48. Chabner E, Nixon A, Gelman R, et al: Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 16:2045-2051, 1998
49. Kurtz JM: Factors influencing the risk of local recurrence in the breast. Eur J Cancer 28:660-666, 1992
50. Pierce LJ, Strawderman MH, Douglas KR, et al: Conservative surgery and radiotherapy for early-stage breast cancer using a lung density correction: The University of Michigan experience. Int J Radiat Oncol Biol Phys 39:921-928, 1997
51. White JR, Gustafson GS, Wimbish K, et al: Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast: The role of preoperative mammograms in guiding treatment. Cancer 74:640-647, 1994
52. Weiss MC, Fowble BL, Solin LJ, et al: Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys 23:941-947, 1992
53. Abner AL, Connolly JL, Recht A, et al: The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 88:1072-1077, 2000
54. Moran M, Haffty BG: Lobular carcinoma in situ as a component of breast cancer: The long-term outcome in patients treated with breast conservation therapy. Int J Radiat Oncol Biol Phys 40:353-358, 1998
55. Sasson AR, Fowble B, Hanlon AL, et al: Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast cancer treated with conservative surgery and radiation. Cancer 91:1862-1869, 2001
56. Elkhuizen PHM, van Slooten H-J, Clahsen PC, et al: High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol 18:1075-1083, 2000
57. Buchholz TA, Tucker SL, Erwin J, et al: Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19:2240-2246, 2001